ACAN and osteoarthritis: HIF-2α downstream degradation factors, such as MMP-3,13 and ADAMTs-4,5, played essential roles in the degradation of cartilage aggrecan and had been recognized as one of the most primary targets for therapeutic intervention in osteoarthritis [21].